New Treatment Has Potential to Minimize Damage After Heart Attack
The drug works by targeting the protein responsible for the death of heart cells during an attack
The drug works by targeting the protein responsible for the death of heart cells during an attack
Immunology-focused pharma company INmune Bio is set to start first-in-man clinical trials with a promising anti-TNF compound that could revolutionize the treatment of Alzheimer’s disease and related symptoms
Join our webinar for a flow cytometry masterclass and learn the tools, tips and tricks to ensure superior cell sorting performance
New machine learning software can forecast the survival rates and response to treatments of patients with ovarian cancer
Lonza and AllCells team up to offer an extensive range of hematopoietic primary cells to reach the global scientific community
Gilson Connect and SciNote aim to overcome the lack of reproducibility across scientific articles
Automation-ready flow cytometer enables biomarker discovery and phenotypic screening
Beckman Coulter Life Sciences has announced its acquisition of Labcyte, a privately held, acoustic liquid handling company based in San Jose, California
Visit BrandTech at Booth 336 to see new Liquid Handling Station flow pipetting robot
From extraction to miniaturized PCR, integrate your workflow for maximum lab efficiency
Discover how the use of high-throughput pipetting tools can facilitate this cutting-edge gene-editing tool
New research suggests that metal-based chemotherapies eliminate inhibitory components of the immune system
Research shows it is now possible to predict what action will be chosen next – the risk or the safe option – based on neuronal activity
Discover a solution that can help you ensure your data is accurate and consistent
New Ultima 2Pplus Delivers Most Advanced and Versatile 3D Photostimulation and Full-Field Imaging for Neurobiology
New Northern Lights Series brings reagent and application flexibility to more labs and enhances performance
New technology enables production of biologically relevant cells to create human models for drug development
Clinical study results suggest individuals with type I or II diabetes may achieve improved glycaemic control with Tresiba
New software saves time and enhances workflow for mid to high complexity flow cytometry testing
The National Center for Tumor Diseases and Protagen AG collaborate to improve information integration